140 related articles for article (PubMed ID: 9272425)
1. Changes in prolactin levels with the menopause: the effects of estrogen/androgen and calcitonin treatment.
Balint-Perić LA; Prelević GM
Gynecol Endocrinol; 1997 Aug; 11(4):275-80. PubMed ID: 9272425
[TBL] [Abstract][Full Text] [Related]
2. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
3. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
Robyn C; Vekemans M
Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
[TBL] [Abstract][Full Text] [Related]
4. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
Moutos D; Smith S; Zacur H
Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
[TBL] [Abstract][Full Text] [Related]
5. [The acute feedback action of exogenously administered oestrogens on the serum-gonadotropin-levels in pre- and postmenopausal women (author's transl)].
Czygan PJ; Reich W
Arch Gynakol; 1973 May; 215(1):17-38. PubMed ID: 4582609
[TBL] [Abstract][Full Text] [Related]
6. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women.
Santoro N; Banwell T; Tortoriello D; Lieman H; Adel T; Skurnick J
Am J Obstet Gynecol; 1998 Apr; 178(4):732-41. PubMed ID: 9579435
[TBL] [Abstract][Full Text] [Related]
7. Pituitary and ovarian function in women receiving hormonal contraception.
Cohen BL; Katz M
Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
[TBL] [Abstract][Full Text] [Related]
8. Laboratory criteria for menopause in women using oral contraceptives.
Creinin MD
Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
[TBL] [Abstract][Full Text] [Related]
9. The pituitary-gonadal axis in women with benign or malignant ovarian tumors.
Blaakaer J; Djursing H; Hørding U; Bennett P; Toftager-Larsen K; Bock JE; Lebech PE
Acta Endocrinol (Copenh); 1992 Aug; 127(2):127-30. PubMed ID: 1388313
[TBL] [Abstract][Full Text] [Related]
10. Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy.
De Leo V; Petraglia F; Bruno MG; Lanzetta D; Inaudi P; D'Antona N
Gynecol Obstet Invest; 1989; 27(2):94-8. PubMed ID: 2499519
[TBL] [Abstract][Full Text] [Related]
11. Acute dopaminergic blockade augments the naloxone-induced LH rise in estrogen-treated postmenopausal women.
Parra A; Barrón J; Marín VA; Coutiño B; Belmont J; Coria I
Maturitas; 1997 May; 27(1):91-9. PubMed ID: 9158083
[TBL] [Abstract][Full Text] [Related]
12. Influence of LH/FSH releasing hormone (LRH) on the basal secretion of gonadotrophins in relation to plasma levels of oestradiol, progesterone and prolactin during the post-partum period in lactating and in non-lactating women.
Jeppsson S; Rannevik G; Thorell JI; Wide L
Acta Endocrinol (Copenh); 1977 Apr; 84(4):713-28. PubMed ID: 322431
[TBL] [Abstract][Full Text] [Related]
13. Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal women.
Faure N; Labrie F; Olivier G; Tremblay M; Cloutier D; Lemay A; Ferland L; Azadian-Boulanger G; Bouton MM; Husson JM; Raynaud JP
Maturitas; 1980 Jul; 2(2):155-68. PubMed ID: 6782429
[TBL] [Abstract][Full Text] [Related]
14. Interactions of oestrogens and hours of sleep on cortisol, FSH, LH, and prolactin in hypogonadal women.
Schiff I; Regestein Q; Schinfeld J; Ryan KJ
Maturitas; 1980 Oct; 2(3):179-83. PubMed ID: 6777633
[TBL] [Abstract][Full Text] [Related]
15. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women.
Lachelin GC; Yen SS
J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women.
Lasco A; Cannavò S; Gaudio A; Morabito N; Basile G; Nicita-Mauro V; Frisina N
Eur J Endocrinol; 2002 Oct; 147(4):461-5. PubMed ID: 12370106
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
Rannevik G; Jeppsson S; Johnell O; Bjerre B; Laurell-Borulf Y; Svanberg L
Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
[TBL] [Abstract][Full Text] [Related]
18. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
[TBL] [Abstract][Full Text] [Related]
19. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
Neoplasma; 1987; 34(1):95-9. PubMed ID: 3104809
[TBL] [Abstract][Full Text] [Related]
20. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
Chakravarti S; Collins WP; Thom MH; Studd JW
Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
